Brain abscess caused by Nocardia farcinica in a person living with HIV.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
03 Oct 2024
Historique:
received: 04 05 2024
accepted: 27 09 2024
medline: 4 10 2024
pubmed: 4 10 2024
entrez: 4 10 2024
Statut: epublish

Résumé

Nocardia farcinica is the most pathogenic Nocardia, which is easy to disseminate. It can be caused by trauma, and even lead to severe lung or central nervous system infection. This report covers a case of Nocardia brain abscess in an HIV patient, who underwent resection of the brain abscess, followed by anti-infective therapy with sulfamethoxazole and meropenem, and eventually made a good recovery. The mortality rate of Nocardia farcinica brain abscess has been attributed to the severity of the underlying disease, the difficulty in identifying the pathogen, and its inherent resistance to antibiotics, leading to inappropriate or late initiation of treatment. Medication should follow the principle of sufficient dosage and sufficient course of treatment.

Identifiants

pubmed: 39363255
doi: 10.1186/s12879-024-10014-x
pii: 10.1186/s12879-024-10014-x
doi:

Substances chimiques

Anti-Bacterial Agents 0
Sulfamethoxazole JE42381TNV
Meropenem FV9J3JU8B1

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1100

Subventions

Organisme : the Hangzhou Biomedical Industry Support Project,
ID : grant number 2024WJC028
Organisme : Zhejiang Traditional Chinese Medicine Science and Technology Program of China
ID : 2024ZL758

Informations de copyright

© 2024. The Author(s).

Références

Corti Me, Villafa E-Fioti M. F. Nocardiosis: a review [J]. Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis. 2003;7(4):243–50.
Fatahi-Bafghi M. Nocardiosis from 1888 to 2017 [J]. Microb Pathog. 2018;114:369–84.
doi: 10.1016/j.micpath.2017.11.012 pubmed: 29146497
Steinbrink J, Leavens J, Kauffman C A, et al. Manifestations and outcomes of nocardia infections: comparison of immunocompromised and nonimmunocompromised adult patients [J]. Medicine. 2018;97(40):e12436.
doi: 10.1097/MD.0000000000012436 pubmed: 30290600 pmcid: 6200467
S, Nchez-Ramos D, Vega-Torres E, Irles-Vidal C, et al. Cerebellious abscesses caused by Nocardia farcinica in an immunocompromised patient [J]. Volume 35. publicacion oficial de la Sociedad Espanola de Quimioterapia; 2022. pp. 418–20. 4Revista espanola de quimioterapia:.
Baio P V, Ramos J N, Dos Santos L S, et al. Molecular identification of nocardia isolates from clinical samples and an overview of human nocardiosis in Brazil [J]. PLoS Negl Trop Dis. 2013;7(12):e2573.
doi: 10.1371/journal.pntd.0002573 pubmed: 24340116 pmcid: 3854972
Lerner P I. Nocardiosis [J]. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 1996, 22(6): 891–903; quiz 4–5.
Mart Nez Tom S R, Men Ndez Villanueva R, Reyes Calzada S, et al. Pulmonary nocardiosis: risk factors and outcomes [J]. Respirol (Carlton Vic). 2007;12(3):394–400.
doi: 10.1111/j.1440-1843.2007.01078.x
Mamelak A N, Obana W G, Flaherty JF, et al. Nocardial brain abscess: treatment strategies and factors influencing outcome [J]. Neurosurgery. 1994;35(4):622–31.
doi: 10.1227/00006123-199410000-00007 pubmed: 7808604
Augustine Kumarva. Nocardia farcinica brain abscess: epidemiology, pathophysiology, and literature review [J]. Surg Infect. 2014;15(5):640–6.
doi: 10.1089/sur.2012.205
Corsini Campioli C, Castillo Almeida N E, O’Horo J C, et al. Clinical presentation, management, and outcomes of patients with brain abscess due to Nocardia Species [J]. Open Forum Infect Dis. 2021;8(4):ofab067.
doi: 10.1093/ofid/ofab067 pubmed: 33855101
Hall W A, Martinez A J, Dummer JS, et al. Nocardial brain abscess: diagnostic and therapeutic use of stereotactic aspiration [J]. Surg Neurol. 1987;28(2):114–8.
doi: 10.1016/0090-3019(87)90083-8 pubmed: 3299825
Hamdi A M, Fida M, Deml SM et al. Retrospective Analysis of Antimicrobial Susceptibility Profiles of Nocardia Species from a Tertiary Hospital and Reference Laboratory, 2011 to 2017 [J]. Antimicrob Agents Chemother, 2020, 64(3).
Brown-Elliott B A, Biehle J, Conville PS, et al. Sulfonamide resistance in isolates of Nocardia spp. from a US multicenter survey [J]. J Clin Microbiol. 2012;50(3):670–2.
doi: 10.1128/JCM.06243-11 pubmed: 22170936
Anagnostou T, Arvanitis M, Kourkoumpetis T K, et al. Nocardiosis of the central nervous system: experience from a general hospital and review of 84 cases from the literature [J]. Medicine. 2014;93(1):19–32.
doi: 10.1097/MD.0000000000000012 pubmed: 24378740 pmcid: 4616325

Auteurs

Lele Yu (L)

Department II of Infectious Diseases, Hangzhou Xixi Hospital, Hangzhou Sixth People's Hospital, Hengbu Street No. 2, Hangzhou, 310023, Zhejiang, China.

Jun Yan (J)

Department II of Infectious Diseases, Hangzhou Xixi Hospital, Hangzhou Sixth People's Hospital, Hengbu Street No. 2, Hangzhou, 310023, Zhejiang, China.

Zhongdong Zhang (Z)

Department II of Infectious Diseases, Hangzhou Xixi Hospital, Hangzhou Sixth People's Hospital, Hengbu Street No. 2, Hangzhou, 310023, Zhejiang, China.

Feng Li (F)

Department II of Infectious Diseases, Hangzhou Xixi Hospital, Hangzhou Sixth People's Hospital, Hengbu Street No. 2, Hangzhou, 310023, Zhejiang, China.

Rongrong Zheng (R)

Department II of Infectious Diseases, Hangzhou Xixi Hospital, Hangzhou Sixth People's Hospital, Hengbu Street No. 2, Hangzhou, 310023, Zhejiang, China.

Jinchuan Shi (J)

Department II of Infectious Diseases, Hangzhou Xixi Hospital, Hangzhou Sixth People's Hospital, Hengbu Street No. 2, Hangzhou, 310023, Zhejiang, China. shijinchuan2008@126.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH